SEEQ Mobile Cardiac Telemetry System
At Medtronic, we focus our growth in areas where we can deliver meaningful innovation and value for patients. In line with this commitment, we have decided to concentrate on the Reveal LINQTM Insertable Cardiac Monitor (ICM) System and discontinue marketing SEEQTM MCT. Medtronic is dedicated to supporting customers through this change.
Beginning May 26, 2018, Medtronic stopped accepting the new SEEQ™ MCT prescriptions.
Patient Data & Reports
As of September 1, 2018, customers no longer have access to SEEQ Online Reporting. Requests for individual patient data should be submitted to MMCsupport@medtronic.com. Please note that requests for a high number of patient reports may not be supported. Inquiries will be managed in accordance with the Medtronic Monitoring, Inc.* retention policy, and may take up to 15 business days to fulfill.
Cardiac monitoring and diagnostics play a significant role in the management of heart patients. Medtronic has led in this important market for many years, and we are committed to an even greater level of involvement in monitoring and diagnostics technologies, focusing on Reveal LINQ ICM.
Please contact your Medtronic Diagnostics sales representative with any questions.
The SEEQ MCT system and Medtronic Monitoring Center are provided by Medtronic Monitoring Inc., a wholly owned subsidiary of Medtronic.